Posters on the Podium

Posters on the Podium

Thursday • May 4, 2023 • 10:30–12:00 Noon CET • Auditorium Level 3
Moderators: Daniela Traini, Ph.D. and Hui Wang, Ph.D.

followed by

Presentation of VCU RDD Peter R. Byron Graduate Student Award

Michael Hindle, Ph.D., Professor, School of Pharmacy
Virginia Commonwealth University, Richmond, Virginia, USA

Evaluation of a Novel Porcine Trachea Cell Airway Model for the Screening of Excipient Toxicity used in Biopharmaceutical Inhalation Products
Rebecca Rittersberger
University of Applied Sciences Biberach
Go with the Flow: Evaluation of a Perfused Calu-3 Model Using a Micro-Physiological System for Inhaled Drug Discovery
Adeel Ahmed
University of Hertfordshire
Benchmarking of Particle Engineering Strategies for Nasal Powder Delivery: Characterization of Nasal Deposition Using the Alberta Idealized Nasal Inlet
Patricia Henriques
University of Coimbra
L-Leucine as a Dispersibility Enhancer in Fully Crystalline Spray-Dried Systems
Mani Ordoubadi
University of Alberta
HFO-1234ze(E): Flammability Characterization for Metered Dose Inhaler Manufacturing
Gregory Smith
Honeywell

Discover More

GD
Filling and Dose Performance of pMDIs with New Low Global Warming Potential Propellants
Gerallt Williams and Gregoire Deraime
Aptar Pharma
Development of a Novel Device Targeting Drug Delivery into the Olfactory Region of the Nasal Cavity
Goncalo Farias
Aptar Pharma
PF
Leachables Assessment from a New Generation of pMDI Using Low Global Warming Potential Propellants
Jose Ferrao and Pauline Faucard
Aptar Pharma
JK
Use of Isothermal Dry Particle Coating (iDPC) for the Development of High Dose Dry Powder Inhalers
David Wyatt and Jasdip Koner
Aston Particle Technologies
KV
Drug Delivery Evaluation of AIRSUPRA™, a Fixed-Dose SABA/ICS Co-Suspension Delivery Technology Combination MDI
David Lechuga and Kou Vang
AstraZeneca
Quadruple Combination in a Pressurized Metered Dose Inhaler with Reduced Environmental Impact for the Treatment of COPD
David Lechuga
AstraZeneca
Comparative Aerosol Performance of an HFA-134a Based Fixed-Dose Triple Combination pMDI to One Made with HFO-1234ze - a Near-Zero Carbon Footprint Propellant
Kellisa Lachacz and David Lechuga
AstraZeneca
KY
Use of Computational Fluid Dynamics Simulations for Localized Deposition Assessment of Inhaled Particles
Kevin Yugulis
Battelle Memorial Institute
Particle Re-entrainment and Wall Loss Reduction Through Utilization of Aqueous Plate Coating in the Next Generation Impactor
Alan Watts
Catalent
MB
Impact of Active Pharmaceutical Ingredient Span and the Amount of Lactose Fines on Dry Powder Inhaler Formulation Performance
Maria Isabel Bogalo Huescar
DFE Pharma
MM
Understanding the Impact of In-Line Sieving on the Filling Behavior of Different Inhalation Powders Using Drum Filling Technology
Karin Marek and Mohit Mehta
Harro Höfliger Verpackungsmaschinen
On the Use of Process Analytical Technology to Expedite Spray Dried DPI Formulations
Maria Ines Lopes
Hovione
Performance of Treprostinil Palmitil Inhalation Powder (TPIP) Delivery System
Zhili Li
Insmed
DROB
An Evaluation of Solution and Suspension pMDIs Containing HFA152a and HFO1234ze Using Clinically Relevant Test Methods
David Riley and Olivia Brittain
Kindeva Drug Delivery
Development of a Particle Sizing Methodology for Early Screening of Carrier-Based DPI Formulations using Laser Diffraction
James McNeill
Kindeva Drug Delivery
JM
Anti-Microbial Properties of Low-GWP pMDI Propellant P-152a
James Murray
Koura
Room Temperature 24-Month Stability of Spray-Dried Bevacizumab Formulation for Dry Powder Inhaler
Kimberly Shepard
Lonza
The Effect of Mixing on the Dispersibility of Adhesive Mixtures for Inhalation
Kyrre Thalberg
Lund University
Chemical Imaging by Raman Spectrometer for Particle Characterization of an Aqueous Nasal Spray
Mridul Majumder
M2M Pharmaceuticals
Production of Amorphous Solid Dispersions at Low Temperature by Electrostatic Spray Drying: Delivery of Thermolabile Compounds with Enhanced Bioavailability
Rodrigo Amorim
Micro-Sphere SA
Microfluidic Aerosol Generation: Breaking Free from Capillary Wave Theory
Jason Brenker
Monash University
Budesonide Nanocrystal Manufacturing Using Controlled Expansion of Supercritical Solutions (CESS®)
Barry Derham
Nanoform
Using a Physiologically Based Pharmacokinetic Model to Investigate the Relationship Between Device, Orientation, Deposition Pattern and the Systemic Exposure of Sumatriptan Nasal Solutions
Will Ganley
Nanopharm, an Aptar Pharma Company
Formulation Technologies Assessment for the Development of Intranasal Powders Comprising a Peptide
Irene Rossi and Paul Shields
Nanopharm, an Aptar Pharma Company
AZ
Assessment of the Realistic Performance of Orbital™ Device Loaded with Model Fluticasone Proprionate Blends Manufactured by Low Shear and Isothermal Dry Particle Coating
Irene Rossi and Antonia Zapata
Nanopharm, an Aptar Pharma Company
EM
Tuneable Nebulizer Platform for Targeted Inhalation Drug Delivery
Elspeth Macdonald
Nebu-Flow
HFA152a MDI Design: Matching the In Vitro Performance of HFA227ea and HFA134a MDIs
David Lewis
Oz-UK Limited
Towards Pharmaceutical Equivalence: A Comparison of Three MDIs: HFA152a, HFA134a, and HFA227ea
David Lewis
Oz-UK Limited
KS
Development of a Pediatric Upper Airway Model as Add-on for a High Repeatability Test Stand for the Measurement of Valved Holding Chambers
Andrea Winzen and Karin Steinfuehrer
PARItec
Comparison of Spray Characteristics of P-134a and Low GWP P-152a pMDIs With and Without Ethanol
Lynn Jordan
Proveris Scientific
Albuterol Sulfate Metered Dose Inhaler Feasibility Using an Environment Friendly Propellant HFA152a and Novel Valves
Lei Mao
Recipharm
Usability Evaluation of a Novel, User-Independent Unit Dose Nasal Spray via Human Factors Studies
Sabrina Falloon and Adam Gibbons
Recipharm
Comparison of Simulated pMDI Droplet Sizes of Fluticasone Propionate Suspension and Solution Formulations to Next Generation Impactor Data
Benjamin Thorne
Recipharm
Effect of Capsule-Based Dry Powder Inhaler User Training on In Vitro Performance
Yannick Baschung
Solvias
Development and Characterization of a Spray-Dried Inhalable Ciprofloxacin-Quercetin Co-Amorphous System Against Pseudomonas Aeruginosa Biofilms
Nasser Ahmed Mohammed Al-hajj
South East Technological University
AW
Evolving Strategies for Designing a Sustainable Inhaler
Prem-Sagar Tank and Alastair Willoughby
Team Consulting
Exploring the Deposition Profile of Salbutamol Sulfate Delivered by Pressurized Metered Dose Inhaler Sampled Via Fast Screening Impactor (FSI)
Mark Nagel and Jolyon Mitchell
Trudell Medical International
Does Replacing an Electromechanical ‘Delay’ Apparatus with a Nephele-Miller Mixing Inlet Yield Similar Outcomes Testing a Pressurized Metered Dose Inhaler With Valved Holding Chamber (pMDI+VHC) Combination?
Mark Nagel and Jolyon Mitchell
Trudell Medical International
Enhancing Extended-Release Profiles of Gelatin Microcapsules Using Ionotropic Gelation and Lipid Coating by Spray Drying
Daniel Moraga-Espinoza
Universidad de Valparaíso
Gelatin Microcapsules as a Platform to Increase Ciprofloxacin Efficacy Against Bacterial Biofilms
Tania Bahamondez-Canas
Universidad de Valparaíso
Droplet Characteristics of Low Global Warming Potential Propellants at Different Ambient Humidities
Hui Wang
University of Alberta
Improved Process and Particle Design in Spray Drying: Adding CFD Analysis to Particle Formation Models
Mani Ordoubadi
University of Alberta
Characterization of the Suitability of a Primary Cell Airway Model from the Porcine Trachea for Uptake and Permeation Studies and as a Potential Model for Mucociliary Clearance
Janik Martin
University of Applied Sciences Biberach
In Vitro Methodologies for the Screening of Nasal Powders: Polymer-Based Formulations
Patricia Henriques
University of Coimbra
Influence of Lung Mucus on In Vitro Dissolution and Absorption of an Inhalable Drug
Rakesh Bastola and Shyamal Das
University of Otago
A Roadmap for Constructing a Beclomethasone pMDI Solution Using HFA152a
Francesca Buttini
University of Parma
Rethinking Dose Delivery and Product Efficiency for the Sustainable Development of Generic DPIs
Francesca Buttini
University of Parma
Investigations into the Relationship Between Spray Dried Powder Particle Size and Deposition in Nose and Lung Analogues when Actuated from a Nasal Device
Jordan Potts
Upperton Pharma Solutions
Multi-Factor Understanding of Vibrating-Mesh Nebulization: Placing Patient Needs at the Center of the Combination Product Development Process
Daniel Lock
Vectura Fertin Pharma
Evaluation of the Impact of Polymorphic Forms of Lactose Having the Same Particle Size on Dry Powder Inhaler Aerodynamic Performance
Çigdem Acar Topaloglu
World Medicine
CO-ORGANIZERS
CONFERENCE SUPPORTERS
↑ Back to Top